VSHP-Thrombolytic Product Conversion Implications for Health System Pharmacy

Speakers:
Joshua Crawford, PharmD, BCPS
System Director, Clinical Pharmacy Services, Bon Secours Mercy Health
Kimberli Burgner, MS, PharmD, BCPS
Capital Division Director Clinical Pharmacy

Presentation Objectives for Pharmacists:
1. Describe electronic medical record changes utilized to help ensure the safe prescribing and administration of tenecteplase
2. Discuss cost savings considerations in converting from alteplase to tenecteplase as the hospital’s main thrombolytic agent
3. List 3 supply chain operational considerations in preparing for the conversion from alteplase to tenecteplase in a large health system
4. Differentiate strategies used to convert thrombolytic agents between two health systems
Presentation Objectives for Pharmacy Technicians:
1. Describe electronic medical record changes utilized to help ensure the safe prescribing and administration of tenecteplase
2. Discuss cost savings considerations in converting from alteplase to tenecteplase as the hospital’s main thrombolytic agent
3. List 3 supply chain operational considerations in preparing for the conversion from alteplase to tenecteplase in a large health system

00:54:00